STACEY RENNER: Open Payments
NPI 1043633985 · BONAIRE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 30 payments from 13 companies in 2025. Trend: 2023 $1,056 · 2024 $1,213 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $261 |
| Novo Nordisk Inc | 3 | $166 |
| Amgen Inc. | 7 | $148 |
| Lundbeck LLC | 4 | $83 |
| ABBVIE INC. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Lilly USA, LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
Products named: FARXIGA, REXULTI, AIRSUPRA, EVENITY, Wegovy, CAPLYTA, OTEZLA, SYNTHROID.
Industry payments across GA — which companies pay providers there.
